Precision BioSciences (DTIL) Misses Q2 EPS by 2c

Precision BioSciences (NASDAQ: DTIL) reported Q2 EPS of ($0.46), $0.02 worse than the analyst estimate of ($0.44). Revenue for the quarter came in at $3.8 million versus the consensus estimate of $4.97 million.

For earnings history and earnings-related data on Precision BioSciences (DTIL) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Tepper’s Appaloosa soars 32% in H1 on prescient memory-chip bets - report
• Morgan Stanley Resumes Gap, Inc. (GAP) at Equalweight